Earnings summaries and quarterly performance for Alignment Healthcare.
Executive leadership at Alignment Healthcare.
John Kao
Chief Executive Officer
Andreas Wagner
Chief Human Resources Officer
Christopher Joyce
Chief Legal & Administrative Officer
Dawn Maroney
President
Jim Head
Chief Financial Officer
Ken Kim
Chief Medical Officer
Robert Scavo
Chief Information Officer
Sebastian Burzacchi
Chief Operating Officer – Management Services Organization
Board of directors at Alignment Healthcare.
Research analysts who have asked questions during Alignment Healthcare earnings calls.
Andrew Mok
Barclays
4 questions for ALHC
Jessica Tassan
Piper Sandler
4 questions for ALHC
Michael Ha
Robert W. Baird & Co.
4 questions for ALHC
John Ransom
Raymond James
3 questions for ALHC
Matthew Gillmor
KeyCorp
3 questions for ALHC
Whit Mayo
Leerink Partners
3 questions for ALHC
Adam Ron
Bank of America Corporation
2 questions for ALHC
Craig Jones
Stifel Financial Corp.
2 questions for ALHC
Jonathan Yong
UBS
2 questions for ALHC
Ryan Daniels
William Blair & Company, L.L.C.
2 questions for ALHC
Ryan Langston
TD Cowen
2 questions for ALHC
Jared Haase
William Blair & Company
1 question for ALHC
Joanna Gajuk
Bank of America
1 question for ALHC
John Stansel
JPMorgan Chase & Co.
1 question for ALHC
Matthew Gilmore
KeyBanc Capital Markets
1 question for ALHC
Scott Fidel
Stephens Inc.
1 question for ALHC
Recent press releases and 8-K filings for ALHC.
- Alignment Healthcare (ALHC) projects 2026 membership growth between 20% and 30%, potentially exceeding 30% due to better-than-expected retention, following 60% growth in 2024 and high 20% growth in 2025.
- The company's 2026 Medicare Advantage bids were optimized for a balance between growth and margin, a shift from 2025 bids which prioritized margin.
- ALHC expects membership outside California to double in 2026 from approximately 35,000 members in 2025, while the overall MA market is anticipated to be relatively flat.
- Operational improvements, including the maturation of the 2024 member cohort and de-delegation of certain IPA functions, are driving margin expansion and improved clinical outcomes, with new member MLRs improving from 90% at enrollment to the low 80s over time.
- For 2027 Stars, the potential elimination of the Health Equity Index (HEI) reward factor is seen as a loss of a "tailwind" that could make achieving 4.5 stars more challenging, though 4-star performance is not predicated on it.
- Alignment Healthcare projects 2026 membership growth between 20% and 30%, potentially exceeding 30% due to strong retention, building on 60% growth in 2024 and high 20s% in 2025.
- The company is expanding margins by 250 basis points in 2025 and designed its 2026 bids for a balanced approach between growth and margin, after favoring margin in 2025 and growth in 2024.
- Alignment expects to double its ex-California membership in 2026 from approximately 35,000 members in 2025, with strong performance in new markets.
- The company anticipates the overall Medicare Advantage market to be relatively flat in 2026 and notes that the elimination of the Health Equity Index (HEI) reward factor for 2027 would remove a tailwind for achieving four and a half stars, though it would not compromise its ability to hit four stars.
- Alignment Healthcare expects 20%-30% membership growth in 2026, potentially exceeding 30% due to better-than-expected retention rates, following 60% growth in 2024 and high 20s% in 2025.
- The company is expanding margins by 250 basis points in 2025.
- For 2026, Alignment optimized its Medicare Advantage bids for a balanced approach between growth and margin, contrasting with a growth-focused 2024 and margin-focused 2025.
- Investments in infrastructure and clinical efficacy, including a transition care program, are expected to improve MLR efficacy and member satisfaction, with all clinical programs anticipated to be deployed in 2026.
- While the overall Medicare Advantage market is expected to be relatively flat in 2026, Alignment anticipates doubling its ex-California membership from approximately 35,000 members in 2025.
- Alignment Healthcare (ALHC) anticipates 20-30% membership growth in 2026, potentially exceeding 30% due to better-than-expected retention rates, following 46% growth in 2025.
- The company's 2025 bids prioritized margin, while 2026 bids were more balanced between growth and margin, with an expectation of expanding margins by 50 basis points in 2025.
- ALHC is enhancing its care delivery model by de-delegating certain functions from IPAs in California, which has resulted in lower admissions per thousand, and plans to fully deploy a transition of care program in 2026 to further improve MLR efficacy.
- For 2027, the proposed removal of the Health Equity Index (HEI) reward factor for star ratings is viewed as a loss of a tailwind for ALHC, potentially impacting its ability to achieve 4.5 stars but not its 4-star performance.
- Alignment Healthcare reported strong Q3 2025 financial results, with health plan membership increasing 26% year-over-year to 229,600 members and total revenue growing 44% year-over-year to $994 million. The company delivered Adjusted EBITDA of $32 million for the quarter.
- The company raised its full-year 2025 guidance, now expecting Adjusted EBITDA between $90 million and $98 million (midpoint $94 million), significantly up from its initial midpoint guidance of $47.5 million. Full-year revenue is projected to be between $3.93 billion and $3.95 billion.
- Alignment Healthcare achieved strong STARS ratings, with 100% of its health plan members in plans rated four stars or above for rating year 2026, payment year 2027, including two five-star contracts in North Carolina and Nevada.
- For the upcoming 2026 Annual Enrollment Period (AEP), the company is confident it is on track to grow at at least 20% year-over-year in membership.
- Alignment Healthcare exceeded guidance metrics for Q3 2025, reporting $994 million in total revenue, a 44% year-over-year increase, and $32 million in adjusted EBITDA. Health plan membership grew 26% year-over-year to 229,600 members.
- The company raised its full-year 2025 guidance, now expecting revenue between $3.93 billion and $3.95 billion and adjusted EBITDA between $90 million and $98 million. This marks the third consecutive quarter of raising full-year guidance.
- For rating year 2026 (payment year 2027), 100% of health plan members are in plans rated four stars or above, including a four-star rating for its California HMO contract and five-star contracts in North Carolina and Nevada. The company's raw score for its primary plan increased to 4.05 or 4.06.
- Alignment Healthcare anticipates at least 20% year-over-year membership growth for 2026, driven by strong AEP results and retention. The company is also exploring tuck-in M&A opportunities related to supplemental benefits and considering expansion into new markets and states for 2027.
- Alignment Healthcare exceeded the high end of its Q3 2025 guidance metrics, reporting total revenue of $994 million, an increase of 44% year-over-year, and Adjusted EBITDA of $32 million. Health plan membership grew approximately 26% year-over-year to 229,600 members.
- The company raised its full-year 2025 guidance for the third consecutive quarter, now expecting revenue between $3.93 billion and $3.95 billion and Adjusted EBITDA between $90 million and $98 million. The midpoint of the full-year revenue outlook increased by $41 million, and Adjusted EBITDA guidance increased by $18 million.
- 100% of Alignment Healthcare's health plan members are in plans rated four stars or above for rating year 2026, payment year 2027. This includes a four-star rating for its California HMO contract (its ninth consecutive year) and two five-star contracts in North Carolina and Nevada.
- Management expects at least 20% membership growth for 2026 and is considering tuck-in M&A opportunities related to supplemental benefits or ancillary captives to improve margins.
- Alignment Healthcare reported Q3 2025 total revenue of $993.7 million, marking a 43.5% year-over-year increase, and achieved net income of $3.7 million.
- The company surpassed the high end of its third-quarter guidance across all key metrics, including membership, revenue, adjusted gross profit, and adjusted EBITDA.
- Health plan membership grew by 25.9% year-over-year, reaching approximately 229,600 members at the end of Q3 2025.
- Alignment Healthcare raised its full-year 2025 outlook, projecting revenue between $3,931 million and $3,946 million and adjusted EBITDA between $90 million and $98 million.
- Alignment Healthcare reported Q3 2025 revenue of $993.7 million, marking a 43.5% increase year-over-year, and health plan membership of approximately 229,600, up 25.9% year-over-year.
- The company surpassed the high end of its third-quarter guidance and raised its full-year 2025 outlook across all key metrics, including membership, revenue, adjusted gross profit, and adjusted EBITDA.
- For the second consecutive year, 100% of its members are in plans rated 4 stars or higher for 2026, which includes two 5-star contracts.
- Adjusted EBITDA for Q3 2025 was $32.4 million.
- Alignment Health Plan, from Alignment Health, has expanded its partnership with Intermountain Health to launch a new 5-star Medicare Advantage (MA) plan with $0 premiums for Medicare-eligible adults in Clark County, Nevada.
- The new plan offers key benefits including $0 copays for primary care, specialist, and urgent care visits, a $25 monthly allowance for healthy groceries, and a $200 FLEX card annual allowance for dental, vision, and hearing services.
- This new offering is Alignment Health Plan's second 5-star plan in Nevada and is built on its legacy Nevada HMO contract, which earned a 5-star rating for rating year 2026.
- Enrollment for the plan is available during Medicare’s annual enrollment period from October 15 to December 7, with coverage starting January 1, 2026.
Quarterly earnings call transcripts for Alignment Healthcare.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more